The inhibitory effects of SLE serum on the expression of HLA-DR and CD80 could be reversed by the addition of anti-IL-10 neutralizing antibodies into the SLE serum (Fig. 5B). This evidence concerns the gene CD80 and systemic lupus erythematosus.